Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.
暂无分享,去创建一个
Dar-Bin Shieh | Fong-Yu Cheng | Chen-Sheng Yeh | Chia-Hao Su | Chao-Liang Wu | D. Shieh | Yu-sheng Yang | C. Yeh | M. Wu | Chao-Liang Wu | Chiau-Yuang Tsai | F. Cheng | Chiau-Yuang Tsai | Yu-Sheng Yang | Ming-Ting Wu | C. Su
[1] P. Bunn,et al. Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer , 1993 .
[2] B. Hamm,et al. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. , 2002, Radiology.
[3] B. Hamm,et al. Preclinical characterization of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as a blood pool contrast medium for MR angiography. , 2002, Academic radiology.
[4] W. L. Jolly,et al. Nitrogen 1s binding energies of transition metal nitrosyls , 1972 .
[5] A. Olukotun,et al. Phase I clinical evaluation of a new iron oxide MR contrast agent , 1994, Journal of magnetic resonance imaging : JMRI.
[6] R. W. Linton,et al. Chemical characterization of hydrous ferric oxides by x-ray photoelectron spectroscopy , 1981 .
[7] Pieter Stroeve,et al. Synthesis and Characterization of Nanometer-Size Fe3O4 and γ-Fe2O3 Particles , 1996 .
[8] Nathan Kohler,et al. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.
[9] C. Beigelman,et al. Iron oxide-enhanced MR lymphography: initial experience. , 2000, European journal of radiology.
[10] P. Reimer,et al. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.
[11] R Weissleder,et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.
[12] P Reichardt,et al. Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.
[13] Peter Wust,et al. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro , 1999 .
[14] S. Mann,et al. Formation of iron oxides in unilamellar vesicles , 1988 .
[15] M. Muhammed,et al. Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles , 2001 .
[16] C. W. Jung. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.
[17] R. Müller,et al. A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The In Vivo Behaviour , 2002, Journal of drug targeting.
[18] L. Vander Elst,et al. Recent developments in design, characterization, and understanding of MRI and MRS contrast media. , 1990, Investigative radiology.
[19] W. Semmler,et al. The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins. , 1997, Journal of drug targeting.
[20] H. Hertz,et al. VM‐26 (Teniposide)-Induced Hypersensitivity and Degranulation of Basophils in Children , 1988, The American journal of pediatric hematology/oncology.
[21] M. Saunders,et al. Magnetite Nanoparticle Dispersions Stabilized with Triblock Copolymers , 2003 .
[22] V. Dravid,et al. Self-assembled (SA) bilayer molecular coating on magnetic nanoparticles , 2001 .
[23] Abraham Ulman,et al. Activity of Candida rugosa lipase immobilized on gamma-Fe2O3 magnetic nanoparticles. , 2003, Journal of the American Chemical Society.
[24] Bernd Hamm,et al. Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance Imaging: Preclinical In Vivo Characterization , 2002, Investigative radiology.
[25] E. Knittle,et al. An XAFS study of the crystal chemistry of Fe in orthopyroxene , 1996 .
[26] W. Lorenz,et al. Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor El® (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions? , 1986, Agents and Actions.
[27] S. Contarini,et al. X‐Ray Photoelectron Spectroscopic Studies of Metal/Inhibitor Systems: Structure and Bonding at the Iron/Amine Interface , 1989 .
[28] T. A. Hatton,et al. Bilayer Surfactant Stabilized Magnetic Fluids: Synthesis and Interactions at Interfaces , 1999 .
[29] Yang,et al. Magnetite Nanoparticles Prepared by Precipitation from Partially Reduced Ferric Chloride Aqueous Solutions. , 1999, Journal of colloid and interface science.
[30] R. Weissleder,et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.
[31] Hao Zeng,et al. Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.
[32] B. Bonnemain,et al. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. , 1998, Journal of drug targeting.
[33] R. Weisskoff,et al. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents , 1992, Journal of magnetic resonance imaging : JMRI.
[34] A. Gedanken,et al. Sonochemical synthesis and characterization of pure nanometer-sized Fe3O4 particles , 2000 .
[35] R. Weissleder,et al. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. , 1990, Radiology.
[36] I. Lucet,et al. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.
[37] Robert E. Lenkinski,et al. Gadolinium-Loaded Nanoparticles: New Contrast Agents for Magnetic Resonance Imaging , 2000 .
[38] C. Bergemann,et al. Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications , 1999 .
[39] U. Schwertmann,et al. The Iron Oxides: Structure, Properties, Reactions, Occurrences and Uses , 2003 .
[40] B Hamm,et al. New generation of monomer‐stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: Preclinical results in rats and rabbits , 2000, Journal of magnetic resonance imaging : JMRI.
[41] Mamoun Muhammed,et al. Characterization and MRI study of surfactant-coated superparamagnetic nanoparticles administered into the rat brain , 2001 .